NCT04664985 - Evaluation of Mucogyne® Ovule in Vulvovaginal Dryness Management in Women Treated by Brachytherapy and/or Radiotherapy for Endometrial or Cervical Cancer. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 6, 2020

Primary Completion Date

August 31, 2022

Study Completion Date

January 31, 2023

Conditions

Vaginal Disease

Interventions

DEVICE

Mucogyne® ovule

hyaluronic acid, vaginal ovule

Trial Locations (7)

Chru Besancon - Site 002, Besançon

Chu Caremeau - Site 001, Nîmes

Clinique Pasteur - Site 005, Toulouse

Chu Nantes - Site 003, Nantes

Institut de Cancerologie de Lorraine - Site 004, Nancy

Leon Berard - Site 007, Lyon

Institut Gustave Roussy - Site 006, Villejuif